Trial Profile
Modulation of Arachidonic Acid Metabolism by Chemopreventive Agents in Smokers
Status:
Discontinued
Phase of Trial:
Phase I/II
Latest Information Update: 08 Dec 2011
Price :
$35
*
At a glance
- Drugs Celecoxib (Primary) ; Zileuton (Primary)
- Indications Lung cancer
- Focus Biomarker; Pharmacodynamics
- 08 Dec 2011 New trial record
- 08 Dec 2011 New trial record